Polylink Polymers (India) Limited (BOM:531454)
26.07
0.00 (0.00%)
At close: Jul 28, 2025
CTI BioPharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.16 | 0.13 | 21.3 | 0.14 | 0.41 | Upgrade |
Short-Term Investments | - | - | 1.15 | - | - | Upgrade |
Cash & Short-Term Investments | 0.16 | 0.13 | 22.45 | 0.14 | 0.41 | Upgrade |
Cash Growth | 23.26% | -99.42% | 15822.69% | -65.19% | -82.08% | Upgrade |
Accounts Receivable | 140.2 | 120.79 | 64.76 | 92.93 | 74.73 | Upgrade |
Other Receivables | - | 2.31 | 0.22 | 0.61 | 1.97 | Upgrade |
Receivables | 140.33 | 123.12 | 64.99 | 93.66 | 76.84 | Upgrade |
Inventory | 70.06 | 67.08 | 51.57 | 47.92 | 45.01 | Upgrade |
Prepaid Expenses | - | 0.49 | 0.36 | 0.52 | 0.47 | Upgrade |
Other Current Assets | 4.05 | 1.1 | 1.01 | 2.5 | 3.28 | Upgrade |
Total Current Assets | 214.59 | 191.92 | 140.38 | 144.74 | 126.01 | Upgrade |
Property, Plant & Equipment | 163.8 | 161.52 | 157.87 | 163.28 | 164.49 | Upgrade |
Other Intangible Assets | - | 0.44 | - | - | - | Upgrade |
Other Long-Term Assets | 18.82 | 2.64 | 2.64 | 2.64 | 3.32 | Upgrade |
Total Assets | 397.21 | 356.53 | 300.9 | 310.67 | 293.82 | Upgrade |
Accounts Payable | 48.88 | 42.59 | 21.27 | 24.63 | 22.65 | Upgrade |
Accrued Expenses | 7.33 | 6.24 | 4.3 | 4.74 | 4.8 | Upgrade |
Short-Term Debt | - | 10.69 | - | 12.36 | 5.27 | Upgrade |
Current Portion of Long-Term Debt | 21.87 | 1.81 | 3.06 | 3 | 3 | Upgrade |
Current Portion of Leases | 0.71 | 0.59 | - | 0.71 | 0.65 | Upgrade |
Current Income Taxes Payable | 1.83 | 1.6 | 1.58 | 1.09 | 1.74 | Upgrade |
Current Unearned Revenue | - | 0.17 | 0.62 | 0.34 | 0.09 | Upgrade |
Other Current Liabilities | 1.67 | - | 0.98 | 0.3 | 1.73 | Upgrade |
Total Current Liabilities | 82.29 | 63.69 | 31.81 | 47.16 | 39.93 | Upgrade |
Long-Term Debt | 1.42 | 3.4 | 1.39 | 2.54 | 4.16 | Upgrade |
Long-Term Leases | 1.81 | 2.52 | - | 0.06 | 0.77 | Upgrade |
Long-Term Deferred Tax Liabilities | 11.83 | 8.78 | 6.76 | 5.55 | 2.77 | Upgrade |
Other Long-Term Liabilities | 0.83 | - | - | - | 0.3 | Upgrade |
Total Liabilities | 98.18 | 78.38 | 40.01 | 55.62 | 47.91 | Upgrade |
Common Stock | 110.56 | 110.56 | 110.56 | 110.56 | 110.56 | Upgrade |
Retained Earnings | - | 167.16 | 149.84 | 143.4 | 134.44 | Upgrade |
Comprehensive Income & Other | 188.48 | 0.43 | 0.49 | 1.09 | 0.91 | Upgrade |
Shareholders' Equity | 299.03 | 278.15 | 260.89 | 255.05 | 245.9 | Upgrade |
Total Liabilities & Equity | 397.21 | 356.53 | 300.9 | 310.67 | 293.82 | Upgrade |
Total Debt | 25.81 | 19.01 | 4.46 | 18.67 | 13.85 | Upgrade |
Net Cash (Debt) | -25.65 | -18.88 | 18 | -18.53 | -13.45 | Upgrade |
Net Cash Per Share | -1.15 | -0.85 | 0.81 | -0.84 | -0.61 | Upgrade |
Filing Date Shares Outstanding | 20.16 | 22.11 | 22.11 | 22.11 | 22.11 | Upgrade |
Total Common Shares Outstanding | 20.16 | 22.11 | 22.11 | 22.11 | 22.11 | Upgrade |
Working Capital | 132.31 | 128.23 | 108.57 | 97.58 | 86.08 | Upgrade |
Book Value Per Share | 14.83 | 12.58 | 11.80 | 11.53 | 11.12 | Upgrade |
Tangible Book Value | 299.03 | 277.7 | 260.89 | 255.05 | 245.9 | Upgrade |
Tangible Book Value Per Share | 14.83 | 12.56 | 11.80 | 11.53 | 11.12 | Upgrade |
Land | - | 62.86 | 62.86 | 62.86 | 62.86 | Upgrade |
Buildings | - | 85.68 | 85.68 | 85.39 | 83.33 | Upgrade |
Machinery | - | 74.45 | 65.44 | 63.8 | 46.24 | Upgrade |
Construction In Progress | - | - | - | - | 11.97 | Upgrade |
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.